TYPE 1 DIABETES MELLITUS
Clinical trials for TYPE 1 DIABETES MELLITUS explained in plain language.
Never miss a new study
Get alerted when new TYPE 1 DIABETES MELLITUS trials appear
Sign up with your email to follow new studies for TYPE 1 DIABETES MELLITUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Smartphone system aims to automate insulin delivery for type 1 diabetes
Disease control TerminatedThis study tests an automated insulin delivery system for adults with type 1 diabetes. The system uses a smartphone connected to a continuous glucose monitor and insulin pump to help keep blood sugar levels in a healthy range, especially overnight. Ten participants compare the au…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: NA • Sponsor: Sue Brown • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Diabetes drug trial halted: could BMF-219 have boosted insulin?
Disease control TerminatedThis study tested an experimental drug called BMF-219 in people with type 1 diabetes to see if it could help their bodies produce more insulin. The trial was stopped early, but researchers planned to compare insulin levels between those who got the drug and those who got a placeb…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: PHASE2 • Sponsor: Biomea Fusion Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New tech approach aims to prevent repeat hospital stays for diabetes patients
Disease control TerminatedThis study tested whether a team-based approach using continuous glucose monitors could help adults with type 1 diabetes better control their blood sugar and avoid another hospital stay after a diabetic ketoacidosis (DKA) episode. Only 2 people enrolled before the study was stopp…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: NA • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could a new drug help preserve insulin production in type 1 diabetes?
Disease control TerminatedThis early-stage trial tested four different doses of siplizumab in 8 people aged 8–45 who were diagnosed with type 1 diabetes within the past 18 months. The goal was to find a safe dose that changes certain immune cell patterns linked to better insulin production. Participants r…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
AI-Powered diabetes coach could replace some doctor visits
Disease control TerminatedThis study tested a software called DreaMed Advisor Pro that automatically analyzes blood sugar and insulin pump data to suggest insulin dose adjustments. About 100 people with type 1 diabetes (ages 6-30) were split into two groups: one received recommendations directly from the …
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: NA • Sponsor: Rabin Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Tablet teaching for diabetes: a High-Tech hope for new patients?
Knowledge-focused TerminatedThis study tested whether using a bedside tablet with interactive education modules helps people newly diagnosed with type 1 diabetes learn more than standard paper-based materials. The trial planned to enroll 28 patients but was terminated early. Researchers measured diabetes kn…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC